Compare KVUE & SHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KVUE | SHG |
|---|---|---|
| Founded | 2022 | 1982 |
| Country | United States | South Korea |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Major Banks |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6B | 28.9B |
| IPO Year | 2023 | 2003 |
| Metric | KVUE | SHG |
|---|---|---|
| Price | $17.13 | $66.75 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $19.45 | N/A |
| AVG Volume (30 Days) | ★ 16.0M | 224.2K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | ★ 4.73% | 2.11% |
| EPS Growth | ★ 40.74 | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | ★ $15,124,000,000.00 | N/A |
| Revenue This Year | $4.85 | $5.16 |
| Revenue Next Year | $2.63 | $3.88 |
| P/E Ratio | $23.08 | ★ $9.79 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.02 | $35.24 |
| 52 Week High | $25.17 | $73.40 |
| Indicator | KVUE | SHG |
|---|---|---|
| Relative Strength Index (RSI) | 41.47 | 55.32 |
| Support Level | $16.70 | $65.09 |
| Resistance Level | $17.20 | $69.85 |
| Average True Range (ATR) | 0.29 | 1.50 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 9.62 | 34.87 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Shinhan Financial Group Co Ltd is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.